Feasibility of romiplostim discontinuation in adult thrombopoietin-receptor agonist responsive patients with primary immune thrombocytopenia: an observational retrospective report in real life clinical practice.
Hematol Rep
; 7(1): 5673, 2015 Feb 24.
Article
em En
| MEDLINE
| ID: mdl-25852848
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2015
Tipo de documento:
Article